Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.1 USD | +0.22% | +0.44% | +6.51% |
06/05 | Lumos Diagnostics Concludes Initial Phase of Development Deal with Hologic for Fetal Fibronectin Test; Shares Jump 6% | MT |
03/05 | JPMorgan Adjusts Price Target on Hologic to $91 From $85 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.51% | 17.76B | |
+7.93% | 219B | |
+7.53% | 184B | |
+15.20% | 138B | |
+27.02% | 108B | |
-0.68% | 62.54B | |
+7.23% | 52.22B | |
+12.58% | 51.73B | |
+1.61% | 41.4B | |
+5.32% | 37.17B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic : Receives CE Mark for Human Cytomegalovirus Quant Assay